Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2005
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/09/2005EP1593683A2 Dihydro-2,3-Benzodiazepine derivatives
11/09/2005EP1593378A1 Remedy for viral disease
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1204632B1 Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005CN1694877A Use of a mixture of esters of fatty acids as fuel or solvent
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226265C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/08/2005US6962767 Acetal compound, polymer, resist composition and patterning process
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005102977A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005CA2564733A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1591434A1 New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1225458C Catalytic reduction of acetylene hydrocarbon compound
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/27/2005WO2005100337A1 Substituted dioxolane derivatives and their use of preparing the neuroregulator
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239799 1-phenyl-4-benzylpiperazines dopamine receptor subtype
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005CN1688567A Alkyl glycidol carbonates used as co-surfactants
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688541A Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097779A1 Diarylamine derivatives as calcium channel blockers
10/20/2005WO2005097100A2 Antibacterial agents
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005CN1683365A Substituted dioxopentacyclic derivative and its use in preparing neuro regulator
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005US6955915 Solid phase synthesis; photolithography
10/13/2005WO2005096422A1 Electrolyte material for solid polymer type fuel cell, electrolyte membrane and membrane electrode assembly
10/13/2005WO2005095377A1 Chemical process
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005US20050228175 Production method of 2-deoxy-L-ribose compound
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227951 Verification of translation
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680361A Preparation of cyclohexene carboxylate derivatives
10/12/2005CN1680360A Preparation of circular carbonate by heterogeneous catalyst with polymer carrier
10/12/2005CN1680340A Novel triazolo pyrimidine compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680269A Process for producing a fluorine-containing compound by liquid phase fluorination
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092934A1 Orthoester-protected polyols for low voc coatings
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092337A1 6 α-OXYMORPHOL AND A METHOD OF USE
10/06/2005US20050222434 Acid-sensitive compounds, their preparation and uses
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005CA2560584A1 Novel compounds for modulating cell proliferation
10/06/2005CA2557439A1 Orthoester-protected polyols for low voc coatings
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951957 Process for producing a fluorine-containing compound by liquid phase fluorination
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 183